Suchergebnisse - "Yeh, Teng-Kuang"

PubPharm (7)

1

Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors

enthalten in: Journal of medicinal chemistry | 2020

von Peng, Y. | Liao, F. | Tseng, C. | +17

ErratumIn: J Med Chem. 2020 Jul 9;63(13):7445. - PMID 32573230

2

A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus

enthalten in: European journal of medicinal chemistry | 2019

von Yeh, T. | Kang, I. | Hsu, T. | +9

3

A Potent, Selective, and Orally Bioavailable HCV NS5A Inhibitor for Treatment of Hepatitis C Virus : (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazol-2-yl)pyrrolidine-2-carboxamide

enthalten in: Journal of medicinal chemistry | 2017

von Kang, I. | Hsu, S. | Yang, H. | +9

4

Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations

enthalten in: European journal of medicinal chemistry | 2015

von Chen, C. | Hsu, J. | Lin, W. | +15

5

Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems

enthalten in: Antimicrobial agents and chemotherapy | 2013

von Lin, H. | Wang, J. | Hu, H. | +10

6

Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor

enthalten in: Antimicrobial agents and chemotherapy | 2012

von Lin, H. | Wang, J. | Hu, H. | +10

7

BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities

enthalten in: Cancer science | 2011

von Hu, C. | Chen, C. | Yeh, T. | +18

1
[1]